MCM
SCLN

McKinley Capital Management’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

McKinley Capital Management’s Portfolio SCLN Stock Details SCLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-2,030
Closed -$21K – 618
2016
Q3 		$21K Buy
+2,030
New +$22.1K ﹤0.01% 480
2015
Q2 		– Sell
-543,110
Closed -$4.81M – 367
2015
Q1 		$4.81M Sell
543,110
-304,469
-36% -$2.43M 0.19% 134
2014
Q4 		$7.42M Buy
+847,579
New +$6.86M 0.3% 97

Other funds holding SCLN

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return

McKinley Capital Management's SCLN Position: Q4 2016 in Review

McKinley Capital Management sold out of Sciclone Pharmaceuticals Inc (SCLN) in Q4 2016, closing a stake of 2,030 shares — an estimated $21K sold.

McKinley Capital Management first reported a position in SCLN in Q4 2014 and held it in 3 quarters. The position peaked at $7.42M in Q4 2014. 153 funds tracked by Wall St. Rank hold SCLN as of Q4 2016.

  • McKinley Capital Management reported no remaining Sciclone Pharmaceuticals Inc position as of Q4 2016 after selling out during the quarter.
  • McKinley Capital Management sold 2,030 Sciclone Pharmaceuticals Inc shares in Q4 2016, an estimated $21K.
  • McKinley Capital Management first reported a position in Sciclone Pharmaceuticals Inc in Q4 2014 and held it in 3 quarters.
  • McKinley Capital Management's Sciclone Pharmaceuticals Inc position peaked at $7.42M in Q4 2014.
  • 153 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q4 2016.

Based on McKinley Capital Management's 13F filing for Q4 2016, filed 14 Feb 2017.